Cargando…
A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT’s) in multiple sclerosis (MS)
BACKGROUND: Physicians commonly advise patients to begin disease modifying therapies (DMT’s) shortly after the establishment of a diagnosis of Multiple Sclerosis (MS) to prevent further relapses and disease progression. However, little is known about the meaning for patients going through the proces...
Autores principales: | de Ceuninck van Capelle, Archibald, van der Meide, Hanneke, Vosman, Frans J. H., Visser, Leo. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570319/ https://www.ncbi.nlm.nih.gov/pubmed/28837609 http://dx.doi.org/10.1371/journal.pone.0182806 |
Ejemplares similares
-
Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist
por: Fox, Edward J., et al.
Publicado: (2019) -
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
por: Buscarinu, Maria Chiara, et al.
Publicado: (2022) -
The Mindful Body: A Phenomenology of the Body With Multiple Sclerosis
por: van der Meide, Hanneke, et al.
Publicado: (2018) -
DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
por: Sormani, Maria Pia, et al.
Publicado: (2021) -
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
por: D’Amico, Emanuele, et al.
Publicado: (2016)